TABLE 1.
Summary of HCC patient clinical parameters in the TCGA and LIRI-JP cohort.
| TCGA-cohort | LIRI-JP cohort | |
|---|---|---|
| Number of patients | 342 | 260 |
| Age | ||
| ≤65 | 216 (63.2%) | 98 (37.7%) |
| >65 | 126 (36.8%) | 162 (62.3%) |
| Gender | ||
| Female | 109 (31.9%) | 68 (26.2%) |
| Male | 233 (68.1%) | 192 (73.8%) |
| Grade | ||
| G1 | 53 (15.5%) | NA |
| G2 | 161 (47.1%) | NA |
| G3 | 111 (32.5%) | NA |
| G4 | 12 (3.5%) | NA |
| Unknown | 5 (1.5%) | NA |
| Stage | ||
| Stage I | 161 (47.1%) | 40 (15.4%) |
| Stage II | 77 (22.5%) | 117 (45.0%) |
| Stage III | 80 (23.4%) | 80 (30.8%) |
| Stage IV | 3 (0.9%) | 23 (8.8%) |
| Unknown | 21 (6.1%) | NA |
| T-stage | ||
| T1 | 168 (49.1%) | NA |
| T2 | 84 (24.6%) | NA |
| T3 | 74 (21.6%) | NA |
| T4 | 13 (3.8%) | NA |
| TX | 1 (0.3%) | NA |
| Unknown | 2 (0.6%) | NA |
| N-stage | ||
| N0 | 239 (69.9%) | NA |
| N1 | 3 (0.9%) | NA |
| NX | 99 (28.9%) | NA |
| Unknown | 1 (0.3%) | NA |
| M-stage | ||
| M0 | 244 (71.3%) | NA |
| M1 | 3 (0.9%) | NA |
| MX | 95 (27.8%) | NA |